Hsueh, Shih Chang
Parekh, Pathik
Batsaikhan, Buyandelger
Vargesson, Neil
Tweedie, David
Luo, Weiming
Patel, Chirag N.
Liu, Dong
McDevitt, Ross A.
Baig, Abdul Mannan
Kim, Yu Kyung
Kim, Sun
Hwang, Inho
Kim, Juwan
Lee, Mee Youn
Carta, Anna R.
Selman, Warren R.
Hoffer, Barry J.
Kim, Dong Seok
Greig, Nigel H. https://orcid.org/0000-0002-3032-1468
Funding for this research was provided by:
National Institute on Aging (AG000994)
Marcus Neuroscience Institute Philanthropic Fund
Ministry of Health & Welfare and Ministry of Science and ICT, Republic of Korea (RS-2024-0034124913)
Korea Drug Development Fund funded by the Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare, Republic of Korea (KDDF RS-2024-00338017)
Article History
Received: 14 April 2025
Accepted: 22 May 2025
First Online: 16 June 2025
Declarations
:
: This is a preclinical (non-clinical) research study that does not require ethics approval and consent to participate for human subjects. All preclinical animal studies were undertaken on fully approved Institutional Animal Care and Use Committee protocols (see Materials and Methods).
: Not applicable (our manuscript does not contain any individual person’s data in any form).
: DSK, YKK, SK, MYL, JK and IH are employed by and have stock in Aevis Bio Inc., which has patent coverage on 3-MP. All other authors declare a lack of competing of interest.